Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Strategic Investment In Leading Gut Health Biotech Ateria Health

Oct 13 (Reuters) - Immuron Ltd  IMC.AX :
    * IMMURON STRATEGIC INVESTMENT IN LEADING GUT HEALTH BIOTECH
ATERIA HEALTH
    * IMMURON SAYS INTENTION TO ENTER INTO RECIPROCAL
DISTRIBUTION
AGREEMENT FOR TRAVELAN® IN U.K. MARKET AND JUVIA™ IN AUSTRALIAN
AND NORTH AMERICAN MARKETS
    * UPFRONT CASH INVESTMENT OF £1.48M FUNDED FROM IMMURON'S
EXISTING
CASH RESERVES
    * NET PROCEEDS WILL BE USED BY ATERIA FOR PRODUCT LAUNCH AND
ONGOING PRODUCT MARKETING OF JUVIA
    * NET PROCEEDS WILL BE USED BY ATERIA RESEARCH AND
DEVELOPMENT
(FURTHER CLINICAL TRIALS) FOR JUVIA PRODUCTS

Source text for Eikon:  ID:nGNX1S9rJC 
Further company coverage:  IMC.AX

Recent news on Immuron

See all news